Skip to main content
SpringerLink
Log in

Oral Fludarabine

A Viewpoint by Dieter Huhn

  • Adis Drug Profile
  • Guest Commentary
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Foran JM, Oscier D, Orchard J, et al. Pharmacokinetic study of single doses of oral fludarabine phosphate in patients with “low-grade” non-Hodgkin’s lymphoma and B-cell chronic lymphocytic leukemia. J Clin Oncol 1999 May; 17(5): 1574–9

    PubMed  CAS  Google Scholar 

  2. Boogaerts MA, Van Hoof A, Catovsky D, et al. Activity of oral fludarabine phosphate in previously treated chronic lymphocytic leukemia. J Clin Oncol 2001 Nov 15; 19(22): 4252–8

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine/Hematology and Oncology, Charitè Campus Virchow-Klinikum, Berlin, Germany

    Dieter Huhn

Authors
  1. Dieter Huhn
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Huhn, D. Oral Fludarabine. Drugs 63, 2324 (2003). https://doi.org/10.2165/00003495-200363210-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-200363210-00005

Keywords

Search

Navigation